06 · FEMETRIC REFERENCE
Side Effects
How to separate adverse events, serious events, discontinuations, warnings and post-marketing reports.Terms that are not interchangeable
An adverse event is an unfavorable occurrence during a study and is not automatically caused by the intervention. Seriousness is a regulatory category, while severity describes intensity. Discontinuation shows that an event or decision ended study treatment.
Percentages need their study context
A frequency belongs to a population, comparator, formulation, dose, duration and reporting window. Do not copy an event rate from one molecule to another or from a trial into an unverified product.
Compound-linked examples
Retatrutide and Tirzepatide trials report gastrointestinal event patterns within source-defined escalation regimens. Tesamorelin labeling includes glucose and IGF-1 monitoring context. These links preserve compound-specific evidence rather than creating a universal list.
When labels matter most
For approved medicines, use the current regulator-approved label for contraindications, warnings and urgent symptoms. Severe allergic symptoms, trouble breathing, fainting or rapidly worsening symptoms require urgent medical attention.